Apoptosis in normal tissues induced by anti-cancer drugs

Area of Science:

• Oncology
• Cell Biology
• Pharmacology

Background:

• Anti-cancer drugs can cause significant damage to normal tissues.
• Apoptosis, or programmed cell death, is a key mechanism by which these drugs exert their effects.
• The gastrointestinal tract and bone marrow are particularly vulnerable to chemotherapy-induced toxicity.

Purpose of the Study:

• To investigate the extent and timing of apoptosis in normal cells of the small intestinal epithelium and bone marrow induced by anti-cancer drugs.
• To evaluate the effects of single and repeated doses of 5-fluorouracil (5-FU) and cisplatin on normal cell apoptosis.
• To explore the potential for preventing drug-induced side-effects by targeting apoptosis.

Main Methods:

• In situ DNA end-labeling and transmission electron microscopy were used to quantify apoptotic cells.
• Mice were administered single or repeated daily doses of 5-FU or cisplatin.
• Apoptosis levels were assessed in the small intestine and bone marrow at various time points post-treatment.

Main Results:

• Both 5-FU and cisplatin induced apoptosis in the small intestine and bone marrow, with peak apoptosis occurring around 36 hours after single doses.
• Cisplatin induced less apoptosis in bone marrow compared to 5-FU.
• Repeated 5-FU administration led to sustained apoptosis in the small intestine, accompanied by diarrhea and villous atrophy.

Conclusions:

• Anti-cancer drugs like 5-FU and cisplatin cause significant apoptosis in normal gastrointestinal and bone marrow cells.
• The timing and extent of apoptosis vary depending on the drug, dosage, and administration schedule.
• Inhibiting apoptosis in the gastrointestinal tract may be a viable strategy to mitigate the side-effects of anti-cancer therapies.